430 related articles for article (PubMed ID: 6400508)
1. Studies of autoimmunity in multiple sclerosis.
Whitaker JN; Snyder DS
CRC Crit Rev Clin Neurobiol; 1984; 1(1):45-82. PubMed ID: 6400508
[TBL] [Abstract][Full Text] [Related]
2. Pathogenesis of myelin/oligodendrocyte damage in multiple sclerosis.
Dhib-Jalbut S
Neurology; 2007 May; 68(22 Suppl 3):S13-21; discussion S43-54. PubMed ID: 17548563
[TBL] [Abstract][Full Text] [Related]
3. The cellular and molecular events of central nervous system remyelination.
Dubois-Dalcq M; Armstrong R
Bioessays; 1990 Dec; 12(12):569-76. PubMed ID: 2080911
[TBL] [Abstract][Full Text] [Related]
4. Clonal expansions of pathogenic CD8+ effector cells in the CNS of myelin mutant mice.
Leder C; Schwab N; Ip CW; Kroner A; Nave KA; Dornmair K; Martini R; Wiendl H
Mol Cell Neurosci; 2007 Nov; 36(3):416-24. PubMed ID: 17889554
[TBL] [Abstract][Full Text] [Related]
5. Homogeneity of active demyelinating lesions in established multiple sclerosis.
Breij EC; Brink BP; Veerhuis R; van den Berg C; Vloet R; Yan R; Dijkstra CD; van der Valk P; Bö L
Ann Neurol; 2008 Jan; 63(1):16-25. PubMed ID: 18232012
[TBL] [Abstract][Full Text] [Related]
6. Identification of autoantibodies associated with myelin damage in multiple sclerosis.
Genain CP; Cannella B; Hauser SL; Raine CS
Nat Med; 1999 Feb; 5(2):170-5. PubMed ID: 9930864
[TBL] [Abstract][Full Text] [Related]
7. The oligodendroglial cell: biology and immunology and relationship to multiple sclerosis.
Bartlett PF; Mackay IR
J Clin Lab Immunol; 1983 May; 11(1):1-7. PubMed ID: 6348293
[TBL] [Abstract][Full Text] [Related]
8. Oligodendrocyte/myelin injury and repair as a function of the central nervous system environment.
Antel J
Clin Neurol Neurosurg; 2006 Mar; 108(3):245-9. PubMed ID: 16384636
[TBL] [Abstract][Full Text] [Related]
9. Spreading of autoimmunity from central to peripheral myelin: two cases of clinical association between multiple sclerosis and chronic inflammatory demyelinating polyneuropathy.
Falcone M; Scalise A; Minisci C; Romito D; Cancelli I; Gigli GL
Neurol Sci; 2006 Apr; 27(1):58-62. PubMed ID: 16688601
[TBL] [Abstract][Full Text] [Related]
10. Demyelination in peroxisomal diseases.
Powers JM
J Neurol Sci; 2005 Feb; 228(2):206-7. PubMed ID: 15694208
[No Abstract] [Full Text] [Related]
11. Bcl-2-expressing oligodendrocytes in multiple sclerosis lesions.
Kuhlmann T; Lucchinetti C; Zettl UK; Bitsch A; Lassmann H; Brück W
Glia; 1999 Oct; 28(1):34-9. PubMed ID: 10498820
[TBL] [Abstract][Full Text] [Related]
12. Molecules affecting myelin stability: a novel hypothesis regarding the pathogenesis of multiple sclerosis.
Mastronardi FG; Moscarello MA
J Neurosci Res; 2005 May; 80(3):301-8. PubMed ID: 15704220
[TBL] [Abstract][Full Text] [Related]
13. Serum antimyelin factors in experimental allergic encephalomyelitis and multiple sclerosis.
Seil FJ; Agrawal HC
Prog Clin Biol Res; 1984; 146():199-206. PubMed ID: 6201891
[No Abstract] [Full Text] [Related]
14. To look for a needle in a haystack: the search for autoantibodies in multiple sclerosis.
Schirmer L; Srivastava R; Hemmer B
Mult Scler; 2014 Mar; 20(3):271-9. PubMed ID: 24589684
[TBL] [Abstract][Full Text] [Related]
15. Remembering MOG: autoantibody mediated demyelination in multiple sclerosis?
Wekerle H
Nat Med; 1999 Feb; 5(2):153-4. PubMed ID: 9930860
[No Abstract] [Full Text] [Related]
16. Immunobiology of oligodendrocytes in multiple sclerosis.
Ruffini F; Chojnacki A; Weiss S; Antel JP
Adv Neurol; 2006; 98():47-63. PubMed ID: 16400826
[No Abstract] [Full Text] [Related]
17. Antibodies to oligodendroglia in patients with multiple sclerosis.
Abramsky O; Lisak RP; Silberberg DH; Pleasure DE
N Engl J Med; 1977 Dec; 297(22):1207-11. PubMed ID: 335246
[TBL] [Abstract][Full Text] [Related]
18. Central nervous system myelin: structure, synthesis and assembly.
Aggarwal S; Yurlova L; Simons M
Trends Cell Biol; 2011 Oct; 21(10):585-93. PubMed ID: 21763137
[TBL] [Abstract][Full Text] [Related]
19. Multiple sclerosis. Oligodendrocyte survival and proliferation in an active established lesion.
Raine CS; Scheinberg L; Waltz JM
Lab Invest; 1981 Dec; 45(6):534-46. PubMed ID: 7321526
[TBL] [Abstract][Full Text] [Related]
20. Multiple sclerosis: in situ evidence for antibody- and complement-mediated demyelination.
Storch MK; Piddlesden S; Haltia M; Iivanainen M; Morgan P; Lassmann H
Ann Neurol; 1998 Apr; 43(4):465-71. PubMed ID: 9546327
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
